Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Addnode Group acquires software company inPort and becomes the Nordic region's leading provider of logistics solutions for ports

Addnode Group has acquired software company InPORT Intelligent PORT Systems AB ("inPort") that develops logistics solutions for ports, terminals and shipping companies. The company is the Nordic region's leading supplier in its market segment and has a net sales of approximately SEK 25 million.inPort has over 25 years of experience in implementing and integrating advanced logistics solutions to its customers. The company's proprietary software suite PORTIT is used by over 90 percent of the Swedish port companies. In recent years, the company has achieved great success outside Sweden's

The Nomination Committee’s proposal for Board of Directors of Indutrade AB for the 2018 Annual General Meeting

The Nomination Committee proposes that Katarina Martinson be elected as Chairman of the Board at the 2018 Annual General Meeting. The Committee also proposes the re-election of Board members Susanna Campbell, Bengt Kjell, Ulf Lundahl, Krister Mellvé, Lars Pettersson and Bo Annvik. Anders Jernhall is proposed as new Board member. The current Chairman, Fredrik Lundberg, has declined re-election. The timing for handing over the Chairmanship is deemed appropriate. Katarina Martinson has extensive knowledge of the company, which will ensure the continuity of the Board’s work. Fredrik

Quality control of biological pharmaceuticals

Attana AB, AstraZeneca, Akzo Nobel Pulp and Performance Chemicals AB and Karlstad University and three more partners have started a new project aiming at developing leading methods for quality control  of production of biological pharmaceuticals.Thursday November 30th the project BIO-QC "Quality Control and Purification of New Biological Pharmaceuticals" was initiated. Biological pharmaceuticals are proteins or similar molecules, which mimics molecules in the body and are injected in the body to stimulate the immune system. - The overall ambition of the project is to provide criteria’

ExpreS2ion and Intravacc enter collaboration agreement

Hørsholm, Denmark / Bilthoven, the Netherlands, December 11, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) and Intravacc (the Institute for Translational Vaccinology), announce the signing of a collaboration agreement. This agreement strengthens ExpreS2ion’s ability to service customers and partners across the full value chain of vaccine development and expands the commercial opportunities for both organisations. Under the agreement, Intravacc will serve as a preferred GMP (Good Manufacturing Practice) partner for ExpreS2ion. The agreement contains no financial exchange between

Announcement of managers' transactions: Security Trading Oy has purchased shares in Caverion Corporation on December 8, 2017

Caverion Corporation Stock exchange release December 11, 2017 at 12.30 p.m. EETAnnouncement of managers' transactions: Security Trading Oy has purchased shares in Caverion Corporation on December 8, 2017 Person subject to the notification requirement Name: Security Trading Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Herlin, Antti Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number:

SKF widens scope of application for its rotor positioning bearings

SKF has augmented its rotor positioning bearings range with a new and compact design that is suitable for all belt-driven starter/generator applications in both 12V and upcoming 48V formats.Gothenburg, Sweden, 11 December 2017: The belt-driven starter/generator (BSG) is the preferred architecture for mild hybrid electric vehicle power train designs. It provides a low cost solution to reduce fuel consumptions and CO2 emissions. The unit enables fast stop/start, regenerative braking and boosting functions. The BSG electronic control unit (ECU) requires instantaneous detection of rotor

Atea Denmark attains highest ISO anti-bribery certification

Atea A/S (Denmark) has become the first organization in Denmark to attain the highest international anti-bribery certification, ISO 37001 – Anti-bribery management systems.To attain the certification, Atea Denmark has worked in a structured and continuous manner for over two years to enhance and document its anti-bribery systems. This has included an evaluation of when the company is at risk of non-compliance with legislation, internal policies and guidelines. Furthermore, Atea Denmark has detailed its business processes, procedures and work culture related to sales to both the public and

NeuroVive reports promising progress in its clinical project for genetic mitochondrial diseases, KL1333

Lund, Sweden, 11 December 2017 – NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and Yungjin Pharm today announced that the phase I clinical study in Korea within the companies’ joint project KL1333, an investigational treatment for genetic mitochondrial disorders, including MELAS (Mitochondrial Myopathy, Encephalopahty, Lactic Acidosis and Stroke-like episodes), is proceeding according to plan.The first part of the study has been successful. The pharmacokinetic data was in line with expectations and no adverse safety signals were detected. The study’s remaining higher

Aker Solutions to Provide Subsea Production System for Aker BP's Ærfugl

December 11, 2017 - Aker Solutions was awarded a contract from Aker BP to deliver the subsea production system for the first phase of the Ærfugl development offshore Norway. The award was made on behalf of the Skarv Unit and is subject to government approval of the plan for development and operation (PDO) of Ærfugl. The subsea system will include wellheads, vertical subsea trees, a tie-in module and an umbilical riser base. The contract includes an option for Ærfugl Phase 2. "We are pleased to have secured this contract," said Executive Vice President Knut Sandvik, who heads Aker

Attana completes share issue

Attana has completed its new share issue and will receive SEK 10.5 million before costs. More than SEK 6.1 million was subscribed for by approximately 500 individuals and the guarantee consortium subscribed an additional SEK 3.9 million. In addition, liabilities of SEK 0.5 million have been settled. The company has applied for listing of the shares on NGM Nordic MTF.The share issue was conducted in accordance with the decision of an Extraordinary General Meeting held on October 10, 2017. The subscription price was SEK 0.60/share and the subscription period ran from the 9th until the 30th of

NEWS; Consensus Statement on Perioperative Use of Neuromuscular Monitoring

Uppsala, December 11, 2017.  A panel of clinician scientists with expertise in neuromuscular blockade (NMB) monitoring was convened with a charge to prepare a consensus statement on indications for, and proper use of, such monitors. This statement was published online at www.anesthesia-analgesia.org on November 30, 2017 (2018 in press), Copyright 2017 International Anesthesia Research Society.The reason for developing the consensus statement was based on a series of reports that indicate a low frequency of routine neuromuscular monitoring and a lack of anesthesia practitioner awareness of

Axactor acquires an unsecured non-performing loan (NPL) portfolio in Sweden

Oslo, 11 December 2017 - Axactor Sweden have acquired a fresh unsecured NPL portfolio. The portfolio includes unsecured credit with a total Outstanding Balance (OB) of approximately EUR6 million, across close to 10,000 open accounts of consumer loans and micro-loans. The portfolio allows Axactor Sweden to get invaluable insight into the rapidly expanding micro-finance sector, as well as including the more vanilla consumer loans. "This acquisition demonstrates Axactor's ability to work with new clients in Sweden and build a well-diversified portfolio. We expect further purchases to follow

Santander Consumer Bank Norway selects Zalaris

Zalaris ASA has signed a five-year contract with Santander Consumer Bank in Norway and will handle BPO transactional HR and payroll Services for almost 600 employees in Norway.Zalaris ASA has signed a five-year contract with Santander Consumer Bank in Norway and will handle BPO transactional HR and payroll services from day one. The project goes live May 1, 2018. “We welcome yet another client in the banking and finance industry to Zalaris, and we are excited to demonstrate our ability to deliver our integrated solutions and services regardless of the clients existing HR system,” says

Valmet to supply OptiConcept M containerboard making line for Shanying International in China

Valmet Oyj's press release on December 11, 2017 at 11:00 a.m. EET Valmet will supply an OptiConcept M  containerboard making line for Shanying International Holdings Co., Ltd., in the city of Jingzhou in Hubei province, China. New production line (PM 21) with a wide automation package is designed to produce high-quality testliner grades. By increasing its production capacity, Shanying is aiming for bigger market shares. The start-up of the machine is scheduled for end of the year 2018. The order

SimCorp A/S – Share buyback program

On 24 August 2017 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 7.5m, to be executed during the period from 24 August 2017 to 31 December 2017. The following transactions have been executed under the program:          Date Number of shares Average Amount (DKK)

East Capital and HMC Capital initiate investment research cooperation for Latin America

East Capital, an independent asset manager specialised in emerging and frontier markets, and HMC Capital, a Latin American financial advisory and investment firm, announce the signing of an advisory service agreement. Under the terms of the agreement, HMC Capital provides Latin American investment research to support East Capital’s global emerging markets capabilities, which have been highlighted recently by the launch of the East Capital Sustainable Emerging Markets fund, benchmarked against the MSCI Emerging Market Index, on June 30, 2017.East Capital and HMC Capital have been working

Eurocine Vaccines Challenges the Flu

While Australia has faced one of the harshest influenza seasons of decades[1] , Eurocine Vaccines prepares for the next phase of development, a second clinical study with its first vaccine candidate Immunose™ FLU, to fight the same. Empowered by the two recently granted patents, in Australia and USA, and positive results from the recently conducted clinical study, Eurocine Vaccines now takes the next step towards the vision - creating the first nasal influenza vaccine approved for children under the age of two. [1] 

Singtel, Ericsson reach Gigabit speeds in LAA trial

Singtel and Ericsson (NASDAQ: ERIC) have achieved an Asia-Pacific first in wireless technology by delivering a peak speed of 1.1 Gbps in a joint trial of a new configuration of Licensed Assisted Access (LAA) technology.Conducted in a Singtel laboratory, the trial delivered speeds that breached the 1 Gbps barrier by combining several key LTE technologies including 256 QAM, 4x4 MIMO, and aggregating two licensed and three unlicensed spectrum bands on a TM500 Test System device[1] 

Percutaneous coronary intervention is a well-justified treatment option also in severe coronary artery disease

The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery. A meta-analysis of several trials and nearly 5,000 patients revealed no differences in mortality between the two treatments. The finding is significant when it comes to selecting the form of treatment: percutaneous coronary intervention is less burdensome on the patient, as it does not require long-term hospitalisation and enables rapid return to work. The prognosis

Greenbyte releases an infographic on renewable energy in Spain

Renewable energy software company Greenbyte releases a series of infographics on renewable energy production in the European Union. After covering Germany, the UK and France, it is time to take a closer look at the renewable electricity generation in Spain.The infographic focuses on data for wind, solar and hydro and sheds light on today’s renewable energy market as well as its evolution in Europe over the past 10 years. “We conducted an analysis of the European renewable energy market for internal purposes and quickly realized that our findings could be of interest not only to our

2018 hot consumer trends: technology turns human

· Consumers expect technology interactions to be controlled by intonation, facial expression and body language · Earphones will become a 24/7 accessory, even when sleeping · 51 percent of Augmented Reality/Virtual Reality users believe artificial intelligence (AI) will render ads indistinguishable from the actual productsExploring the future from an early adopter user perspective, Ericsson (NASDAQ: ERIC) ConsumerLab presents the seventh edition of its annual trend report, The 10 Hot Consumer Trends for 2018 and beyond 

Panion’s epilepsy product classified as MUMS in EU for dogs and cats

Panion Animal Health AB has received the European Medicines Agency’s acceptance of the classification as MUMS (Minor Use Minor Species) for our epilepsy product for both dogs and cats. The request for classification was submitted to the Committee for Medicinal Products for Veterinary Use (CVMP) in the European Medicines Agency (EMA) earlier in 2017 and has now been successfully evaluated.The MUMS status is granted to assist applicants that intends to develop and submit applications for products for limited markets in order to stimulate development of new medicines. The measures made

There are no items matching the current filter
There are no more items matching the current filter
Back to top